sJIA CD14 monocytes show specific, defective STAT1 phosphorylation downstream of IFNs.
sJIA monocytes express higher transcript levels of the IFN signaling inhibitor SOCS1.
Recent changes in medication use in sJIA may alter the IFN hyporesponsiveness.
Impaired IFN/pSTAT1 signaling consistent with monocyte skewing away from M1 phenotype
Impaired IFN/pSTAT1 signaling may contribute to disease pathology in sJIA.